PhD by White, Harold Steve
IN VIVO AND IN VITRO EFFECTS OF PHENYTOIN ON ANION 
AND CATION TRANSPORT SYSTEMS OF THE RAT BRAIN 
by 
H. Steve White 
A dissertation submitted to the faculty of the University 
of Utah in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
Department of Pharmacology 
The University of Utah 
March 1984 
THE UNIVERSITY OF UTAH GRADUATE SCHOOL 
FINAL READING APPROVAL 
To the Graduate Council of The University of Utah: 
1 have read the dissertation of Haro] d Steve Wbi te m ItS 
final form and have found that (1) its format, citations. and bibliographic style are 
consistent and acceptable; (2) its illustrative materials including figures, tables, 
and charts are in place; and (3) the final manuscript is satisfactory to the Supervis­
ory Committee and is ready for submission to the Graduate School. 
24 Feb. 1984 
Date 
Chairperson. Supervisory Commillee 
Approved for the Major Department 
Dona] . Reed, Ph.D. 
Chairman I Dean 
Approved for the Graduate Council 
James L. C]ayton, Ph.D. 
Dean of The Graduate School 
THE UNIVERSITY OF UTAH GRADUATE SCHOOL 
SUPERVISORY COMMITTEE APPROVAL 
of a dissertation submitted by 
Harold Steve White 
This dissertation has been read by each member of the following supervisory committee and by 
majority vote has been fou nd to be satisfactory. 
22 Q��. 1983 · 
Date 
22 Dec. 1983 
Date 
22 Dec. 1�8� 
Date 
22 Dec. 1983 
t! 
r"b 
Date Glen R. Hanson, Ph.D. 
22 Dec. 1983 
� 
� .fZ""?� 
Date Jack A. Madsen, M.D. 
THE GRADUATE SCHOOL 
UNIVERSITY OF UTAH 
REPORT OF THE FINAL EXAMINATION 
FOR THE Ph.D. X ,Ed.D. __ OR M.Phil. __ DEGREE 
Date December 21, 1983 
Return one copy signed by committee to: 
Graduate School 
402 Park Building 
NameofStudent ____ ~H~a_r~o_1~d_S_t~e~v~e_W~h~1~·t~e~ __________________________ __ 
Major Field __ P...;..h...;..a..;..,rm_a...;..c;..;o;...;.l...;;.o"""gy_' __________ Minor Field __________ _ 
(For Ed.D Degree) 
Date of Examination December 22, 1983 
The student's examination was evaluated as follows by the Committee: 
Passed _-J.X"",,,,-__ Failed ___ _ 
The student's dissertation was evaluated as follows by the Commjttee: 
Passed _....:X~ __ Failed ___ _ 
IN VIVO AND IN VITRO EFFECTS OF PHENYTOIN ON ANION 
AND CATION TRANSPORT SYSTEMS OF THE RAT BRAIN 
by 
H. Steve White 
An abstract of a dissertation submitted to the faculty of 
The University of Utah 
in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy 
Dixon M. Woodbury Chairman, Supervisory Committee 
Prof essor of Pharmacology 
Department of Pharmacology 
The University of Utah 
March 1984 
Copyright© H. Steve White 
All rights reserved, 1984 
ABSTRACT 
Various parameters of anion and cation transport were measured in the 
cerebral cortex of neonatal (3 days old) and adult rats following acute and chronic 
treatment with PHT. Acutely, phenytoin (PHT) significantly inhibited the enzyme 
Na+, K+-ATPase in both neonatal and adult rats. This effect was accompanied by 
a significant increase in cerebral cortical sodium (Na+) content and a decrease in 
potassium (K+) content only in neonatal animals. Chronic treatment (bid and qid 
for 7 days) of adult rats with PHT significantly reduced the Na+ content without 
affecting the whole homogenate Na+, K+ -ATPase activity. The activity of this 
enzyme was markedly increased in the myelin- (glial product) and slightly 
decreased in the synaptosomal- (neuronal) fractions following chronic (qid for 7 
days) PHT treatment. These results suggest that PHT differentially affects the 
two forms (neuronal and glial) of the enzyme Na+, K+ -ATPase. The possible 
relevance of this hypothesis in relationship to the anticonvulsant and excitatory 
properties of PHT is discussed. 
Chronic (bid and qid for 7 days) PHT treatm ent increased both DNA content 
and activity of the glial marker enzyme carbonic anhydrase. Activity of the 
mitochondrial enzyme He03 --ATPase was also increased following chronic PHT 
treatment. These two enzymes are intimately involved in the regulation of 
HC03 --CI- transport across glial cell and mitochondrial membranes, and these 
results suggest that PHT is able to beneficially effect glial regulatory processes. 
The ability to enhance glial regulation of extracellular fluid anions and cations 
provides new and important insights into the mechanism of the anticonvulsant 
action of PHT. 
The activity of enzymes involved in anion and cation transport, the 
concentration of intracellular potassium (K+ i)' and the trans-membrane potential 
(Em) was determined following acute and chronic exposure of primary astroglial 
cultures to micromolar concentrations of phenytoin (PHT). Na+, K+-ATPase 
activity of homogenates of cultured glial cells was determined in the presence of 
increasing K+ concentration (1-20 mM). Acutely, PHT had little effect on the K+-
activation pattern of Na+, K+-ATPase. In contrast, the percent of Na+, K+-
ATPase activated by elevating the K+ concentration was dose-dependently 
increased by chronic PHT treatment. This effect was accompanied by a marked 
increase in K+i and a significant membrane hyperpolarization. The acute effect 
of PHT on the Em was biphasic, characterized by membrane hyperpolarization at 
concentrations of 1 x 10-6 to 1 x 10-5 M. At concentrations between 1 x 10-5 M 
and 1 x 10-4 .M, the Em progressively returned to control values. These results 
suggest that glial cells acutely and chronically treated with therapeutic 
concentrations of PHT have an enhanced capacity to control elevated 
extracellular potassium. Return of the Em to control values at PHT 
concentrations greater than 1 x 10-5 M suggest that these cells are less able to 
regulate extracellular potassium. These data can partially explain the excitatory 
effects of PHT at high therapeutic concentrations. 
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PART ONE 
EFFECTS OF ACUTE AND CHRONIC PHENYTOIN ON THE ELECTROLYTE 
CONTENT AND THE ACTIVITIES OF NA +, K+ -, CA ++, MG++-, 
HC03--ATPase AND CARBONIC ANHYDRASE OF 
NEONATAL AND ADULT RAT 
CEREBRAL CORTEX 
INTRODUCTION 
The available experimental evidence suggests that one of the major actions 
of PHT is on the movement of sodium (Na+) (Lipicky, et al., 1972; Schwartz and 
Vogel; 1977) and calcium (Ca++) (Pincus, 1972; Sohn and Ferrendelli, 1973 de 1976) 
across biological membranes. Through an interaction with either passive or active 
transport mechanisms, it has been observed to decrease both Na+ and Ca++ influx 
and consequently, it decreases intracellular Na+ and Ca++ concentrations in the 
cytosol. These effects tend to stabilize neuronal membranes and have been 
postulated to be the basis for its anticonvulsant activity. A decrease in Na+ 
and/or Ca++ permeability cannot explain PHT's excitatory effect in neonatal 
animals and in adults with high doses unless it selectively affects inhibitory 
neurons (for discussion, see Woodbury 1982). In neonatal animals, however, this is 
inconsistent with both anatomical and biochemical evidence suggesting that 
cerebral and cerebellar cortical inhibitory circuits are poorly developed. Under 
normal circumstances inhibitory output predominates over excitatory output in 
the adult central nervous system (CNS), as suggested by the observation that 
blockade of GABA mediated inhibition with bicuculline produces intense seizure 
activity_ Therefore, a decrease in Na+ and Ca++ permeability would tend to 
stabilize inhibitory neurons, and produce excitatory rather than anticonvulsant 
effects through a disinhibition of excitatory pathways. This discrepancy between 
anticonvulsant action and these proposed mechanisms has led us to investigate the 
hypothesis that PHT is primarily an excitatory drug that possesses anticonvulsant 
activity by virtue of its ability to stimulate predominating inhibitory pathways of 
the adult CNS. Previous reports have demonstrated that PHT is capable of 
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facilitating pOlysynaptic inhibitory systems (Davidoff, 1972; Halpern and Julian, 
1972; Raabe and Ayala, 1976; Fromm, et al., 1981a, 1981b, and 1982). From this, it 
would appear that the net effect of PHT administration depends on the 
predominating system (excitatory or inhibitory) at the time it is given. In 
neonatal animals for example, stimulation of predominating excitatory pathways 
by PHT produces an enhanced excitatory CNS output. In contrast, PHT stimulates 
both excitatory and inhibitory CNS pathways, in the adult CNS, but because 
inhibitory pathways predominate, the end result, at least in low doses, is one of 
inhibition (anticonvulsant effect) rather than excitation, whereas in high doses 
excitatory effects appear. 
The CNS of the adult rat is comprised of two functional cell types (i.e., the 
neuron and the glia). In light of increasing evidence supporting a regula tory role 
for glial cells in maintaining ionic and acid-base homeostasis, it seems reasonable 
to expect that they would be involved not only in epileptogensis (Pollen and 
Trachtenberg, 1970; Grisar et al., 1983), but also in the prevention of seizure 
spread. Furthermore, it follows, that PHT through an interaction with glial 
regulatory processes, can provide the CNS with an enhanced ability to regulate 
the ionic and acid-base homeostasis within the brain extracellular fluid (ECF), 
thereby limiting the spread of seizure activity. Thus, by identifying specific 
biochemical alterations attributable to acute and chronic administration of PHT, 
we attempted in the present investigation to characterize both the neuronal and 
the glial components that contribute to PHT's antiepileptic, excitatory and toxic 
effects. The cellular heterogeneity of the adult CNS, however, makes it difficult 
to draw associations between a specific drug effect and a particular cell type. To 
circumvent this problem, the studies described in the present report were 
conducted in both neonatal and adult rats. At postnatal day 3, the neuropil of the 
CNS is comprised primarily of nerve cells and effects observed following 
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treatment with PHT at this age, reflect a direct interaction between PHT and 
neuronal cells. On the other hand, the adult CNS is comprised of functional 
neuronal and glial cells, and effects observed following treatment with PHT at 
this age refiect a direct or indirect effect on neuronal and/or glial cells. 
In addition to the glial marker enzyme carbonic anhydrase, the activities of 
Na+ K+-, Ca++, Mg++-, and HC03--ATPase and the electrolyte (Na+, K+ &: CI-) 
content of the cerebral cortex were determined following acute and chronic PHT 
treatment of neonatal and adult rats. Because changes in the activities of these 
transport enzym es can have a significant influence on the level of CNS 
excitability by altering electrolyte (Na+, K+, and CI-) homeostasis, it is important 
to define and characterize the effect of PHT on these processes. 
METHODS AND PROCEDURES 
Animals 
Neonatal (postnatal day 3, males and females) and adult (250 gm-males) 
Sprague-Dawley rats were used in all experiments. Pregnant females were 
obtained from an in-house breeding colony, and served as the source for all 
neonatal pups. Adult males were purchased from Simmonsen Laboratories, Gilroy, 
California. Upon shipment, animals were allowed 7-10 days to acclimatize. All 
rats were housed in a temperature and humidity controlled environment, and 
allowed free access to Purina Rat Chow and water ad libitum. Lighting was 
maintained on a 12-hour on, and a 12-hour off cycle (on 0800, off 2000 hours). 
Drug Treatment 
Time-Response. Neonatal (n = 5-8 per group) and adult rats (n = 8 per group) 
received an anticonvulsant dose of PHT (20 mg/kg, ip) at various times (15, 30, 60, 
120, and 240 min) prior to electroshock testing and/or sacrifice. Control animals 
received an equivalent volume of vehicle (5% gum Arabic) at similar time 
intervals prior to sacrifice. 
Dose-Response. Varying doses of PHT (10, 20, 40, and 80 mg/kg) were 
administered intraperitoneally to adult rats (n = 8 per group) two hours prior to 
electroshock testing. 
Acute and Chronic Effect. Two hours prior to sacrifice, neonatal (n = 6 per 
group) and adult animals (n = 7-8 per group) received one acute dose of PHT (20 
mg/kg, ip). To evaluate the chronic effects of PHT on various biochemical 
parameters, two control and two treated groups were employed. One group of 
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adult male rats was given PHT (20 mg/kg, ip) twice daily for 7 days, while the 
other treatment group received an equivalent dose (20 mg/kg) four-times-a-day 
for 7 days. The two control groups received a similar volume of vehicle twice-a-
day and four-times-a-day for 7 days. Animals were sacrificed two hours after the 
last dose. 
Anticonwlsant Testing 
Maximal electroshock seizures (MES) were elicited with a current intensity of 
150 ma for 0.2 sec delivered through corneal electrodes at 60 Hz. Endpoint for 
anticonvulsant effect was taken as the abolition of hindlimb extension. The total 
length of the tonic phase (flexion + extension) of the seizure, the extension and 
flexion time, and the extension/flexion (E/F) ratio of those animals not protected 
against a MES stimulus was also recorded. This method has been previously 
described by Swinyard (1949). 
Minimal electroshock seizure threshold (EST) was determined according to 
the "staircase" procedure of Finney (1952), and described in detail by Swinyard 
(1972). Increasing and decreasing increments of current (60 Hz) are delivered for 
O.2-sec stimulus duration through corneal electrodes. The presence or absence of 
a minimal seizure characterized by clonic activity of the vibrissae, lower jaw, or 
forelimbs was taken as the endpoint. An estimation of the convulsive current 
fifty (cc50) and calculation of the 9596 confidence limits were carried out using 
the graphic method of Litchfield and Wilcoxon (1949). These methods and their 
interpretation have been discussed in detail by Swinyard (1972). 
MES and EST patterns of adult rats were determined, using an electroshock 
apparatus designed by Woodbury and Davenport (1952). 
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Sample Collection and Biochemical Assay Procedures 
Just prior to sacrifice, each animal was anesthetized with ether. Within 2 
minutes of exsanguination, a 25-100 microliter (ul) sample of cerebrospinal fluid 
(CSF) was taken from the cisterna magna with a 0.1 ml tapered capillary tube, and 
weighed. Animals were perfused through the left ventricle of the heart with ice-
cold isotonic sucrose. The whole brain was removed, and carefully dissected on a 
ice-cold aluminum plate. One-half of the cerebral cortex was placed on a 
preweighed parafilm, reweighed and frozen (-200 C) until further analysis could be 
performed. The remaining tissue was placed into a preweighed vial for 
determination of water and electrolyte (Na+ , K+, and CC) content. 
Enzymatic Assays. On the day of analysis, tissues were homogenized in ice-
cold distilled water (final concentration of 25 mg tissue/ml water) for 
determination of carbonic anhydrase activity and to 1 mg/ml for determination of 
Na+, K+-,HC03 -, and Ca++, Mg++-ATPase enzymic activity. Carbonic anhydrase 
activity was estimated according to the method of Maren (1960). Na+, K+-, 
HC03-, and Ca++, Mg++-ATPase enzymic activities were determined by our 
modifications of the procedures of Bonting (1970), Kimelberg and Bourke (1973), 
and Stekhoven and Bonting (1981), respectively. Shown in Table 1 are the 
concentrations and amounts of the solutions used in each assay for the 
determination of Na+,K+- and HC03--ATPase activity. 
After a S to 10 min preincubation, Na2ATP (5 mM final concentration) was 
added. The reaction was terminated by the addition of 0.02 ml of 2.5 M HCI04 
after a S min inCUbation. The inorganic phosphate released was determined by a. 
modification of the method of Itaya and Oi (1966) using malachite green dye. The 
optical density wa.s read at a wavelength of 640 nm after 6 minutes of color 
development. The amount of phosphate was determined from the regression 
equation of a phosphate standard curve, and the activity of N a +, K+ -ATPase (nM 
Table 1. COMPOSITION OF BUFFERS USED FOR THE DETERMINATION OF Na+,K+- and HC03--ATPase ACTIVITY. 
Na+, K+-ATPase Mg++-ATPase HCO)--ATPase Mg++-ATPase 
ml ml ml ml 
Tissue homogenate 0.1 0.1 0.1 0.1 
Buffer 0.1 pH 7.4 0.1 pH 7.4 0.1 pH 8.7 0.1 pH 8.7 
MgS04(5mM) + + + + K S04(5mM) + N~2S04(60mM) + + +(40mM) + 
EDTA(O.lmM) + + + + 
TRIS (92mM) + + + + 
NaHCO (2OmM) + ATP(6~M) 0.02 0.02 0.02 0.02 
Ouabain (lmM) 0.02 0.02 
Water 0.02 0.02 
Total Volume 0.24 0.24 0.24 0.24 
(+)-present in buffer system. 
(-)-absent in buffer system. 
00 
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of Pi/mg protein/min) was that amount inhibited by 1.0 mM ouabain. This method 
has been determined to be sensitive to 6 nmoles of phosphate and is somewhat 
more sensitive than methods which detect p-nitrophenol (Anderson and Kemp, 
unpublished observations). 
Ca++ -activated, Mg++ -dependent enzyme activity was also determined 
according to our modification of the method of Stekhoven and Bonting (1981). 
One hundred microliters of tissue homogenate was incubated under identical 
conditions as described above, in a buffer containing 48 mM Histidine-HCI, 12 mM 
MgCI2, 1.2 mM EGrA, and 1.2 mM CaCl2 (pH 7.0). The Mg++-activated ATPase 
activity was determined in a buffer composed of 48 mM Histidine-HCL, 12 mM 
MgCI2, and 1.2 mM EGTA (pH 7.0). 
Subcellular Fractionation. Subcellular fractionations were performed on 
cerebral cortical tissue obtained from vehicle-treated controls and chronic PHT-
treated animals (20 mg/kg, ip, qid for 7 days). Fractionation procedures were 
conducted at 40 C in a Beckman L5-65B centrifuge according to the method of 
Gray and Whitaker (1962). Whole homogenate, microsomal, synaptosomal, myelin 
and mitochondrial fractions were assayed for Na+, K+-, Ca++, Mg++- and HC03--
ATPase and carbonic anhydrase activity. 
Electrolyte Content. Measurement of brain tissue extracellular space (ECS) 
from 36Cl- uptake curves (Smith et al., 1981), total H20, and total electrolyte 
content provides the necessary data for adequately estimating the intracellular 
electrolyte concentration. Intracellular concentrations of N a + (N a + i)' and K+ 
(K+ i) were estimated by subtracting the extracellular electrolyte content from the 
total electrolyte content and correcting for water content. Extracellular 
electrolyte content was obtained from the product of the fractional ECS tim es the 
CSF electrolyte concentration. This method has been described previously by 
Smith et ale (1981). CSF electrolyte (Na+, K+ and Cl-) content was determined on 
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the day of sacrifice. CSF was diluted 1:200 with a solution containing 15 meq/l 
Lithium (Li++). The concentrations of Na + and K+ (meq/l) were determined 
directly on this solution with an Instrumentation Laboratory, Inc. flame 
photometer. Chloride content was estimated with a Buchler-Cotlove 
chloridometer after mixing I ml of the above solution and 3 ml nitric acid reagent 
(containing O.IN HN03 and 1.8N acetic acid). 
Tissue water content was determined by dessication at 600 C for 24-48 
hours. Tissue Na+ and K+ content was determined by flame photometry. Fifty 
milligrams of dry tissue was first extracted in 8.0 ml of a 1.0 N HN03 solution 
containing 15 meq/l Li++ for 18-24 hours. On the day of analysis, a 1:5 dilution of 
tissue extract with acid Li++ was made, and the content of Na + and K+ 
determined. Tissue Cl- content was estimated by a Buchler-Cotlove 
chloridometer after mixing 0.5-1.0 ml of tissue extract with 3.5-4.0 ml nitric acid 
reagent (containing O.IN HN0 3 and 1.8 N acetic acid). 
ON A and Protein Assays. The ON A content of the cerebral cortex was 
determined in triplicate according to our modifications of the method of 
Hinegardner (1971). One hundred microliters (0.1 ml) of tissue homogenate 
(lmg/ml) was placed into a 6 x 50 mm disposable glass culture tube, and 
centrifuged at 4000 rpm for 20 min. The supernatant was carefully aspirated with 
a tapered 0.1 ml capillary tube attached to the house vacuum line, and discarded. 
The remaining pellet was incubated with 0.020 ml of diaminobenzoic acid (33% 
w/v) at 600 C in a temperature controlled aluminum block for 45 min. At the end 
of this time, the reaction was stopped by adding 0.3 ml of 1.0 N HCl to each 
tube. Samples were vortexed to insure adequate mixing and the relative 
fluorescence of each sample was determined with an Aminco-Bowman 
Spectrophotofluorometer (excitation wavelength-410 nm; emission wavelength-S10 
nm). ON A content was estimated from a standard curve using Calf Thymus as a 
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standard. By using 6 x 50 mm culture tubes and reducing the sample volume, we 
have found the sensitivity and linearity of this method to be in the range of 10 -
200 nanograms of total DN A. 
Protein content of individual cultures was determined in triplicate by the 
method of Lowry et ale (1951) using bovine serum albumin as a standard. 
Statistical Analysis 
Six or more animals were used for each experimental group. Data analysis 
involved calculation of means, standard deviations, and standard errors of the 
means for each experimental group. The unpaired student's t-test was used to 
determine significant differences in enzyme and electrolyte contents between 
controls and treated groups. Unless otherwise stated, differences between means 




Anticonvulsant and Excitatory Effects 
The peak anticonvulsant effect of PHT (20 mg/kg), as measured by changes in 
MES patterns was observed 2-hours after a single dose (Fig. 1). At this time, 6796 
of the animals tested were protected against a maximal electroshock seizure (A). 
In unprotected animals PHT decreased seizure duration (B), decreased total time 
of hind-limb extension (C), and decreased the extension to flexion ratio (ElF ratio) 
(D). As illustrated in Fig. 2, the dose producing peak protection against MES was 
20 mg/kg. Above this dose (20 mg/kg), PHT increased the seizure duration (A), 
and the extensor component (B) progressively to above control levels, decreased 
the flexor component (B) above 40 mg/kg, and increased the ElF ratio (C) to pre-
drug control values. 
As demonstrated previously by other investigators, PHT (20 mg/kg) did not 
significantly affect the EST (Fig. 3-top). A significant regression between PHT 
dose and EST was, however, observed at 30 min as illustrated in Fig. 3-bottom. 
Effect of PHT on Cerebral Cortex Electrolytes 
and Enzymic Activity 
The effects of acute and chronic PHT administration on neonatal and adult 
rat cerebral cortical Na+ and K+ content, and the activity of Na+, K+-ATPase 
(whole homogenate activity) are summarized in Fig. 4. Acute PHT treatment of 
neonatal animals significantly inhibited cerebral cortical N a +, K+ -ATPase. 
Consistent with this effect, a significant increase in total tissue Na+, and a 
significant decrease in total tissue K+ was observed. Na+, K+ -ATPase activity 
was markedly attenuated following acute PHT treatment of adult animals (Fig. 4), 
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Fig. 1. Acute anticonvulsant profile of PHT in adult rats. At various times after 
PHT administration (20 mg/kg, ip), animals were tested for protection (%) (A) 
against maximal electroshock induced seizures as described by Swinyard (1949). A 
60 hz, 150 rna stimulus (0.2 sec duration) was delivered to treated and control 
animals through corneal electrodes. The total length (sec) of the tonic phase 
(flexion + extension) of the seizure (B), the extension and flexion time (sec) (C), 
and the ElF ratio (D) of animals not protected against a MES stimulus were also 
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Fig. 2. The effect of increasing PHT dose on various anticonvulsant indices. 
Increasing doses (10, 20, 40, and 80 mg/kg) were administered to adult male 
Sprague-Dawley rats two hours prior to anticonvulsant testing (see legend to Fig. 
1, and methods for explanation). Twenty-four hours prior to PHT treatment, each 
animal received a MES stimulus and the seizure length (A), the extension and 
flexion times "(B), and the E/F ratio were recorded. In this way each animal served 
as its own control. The results are thus expressed as a percent of these pre-drug 
* control values and represent the mean ± the SEM. ( p < 0.05). 
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Fig. 3. Time- and dose-effect of PHT on the electroshock seizure threshold of 
adult rats. At various times (top) after a single dose (20 mg/kg, ip) of PHT, the 
seizure threshold of control and treated rats was determined according to the 
staircase procedure of Finney (1952). The acute dose-effect of PHT (bottom) on 
the EST was determined 30-minutes after PHT treatment. Each pOint represents 
the current (rna) necessary to produce a minimal seizure in 5096 of the animals 
tested. Ninety-five percent confidence limits are shown for the top curve. 
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Fig. 4. Effect of acute and chronic PHT treatment on neonatal and adult rat 
cerebral cortical Na+ and K+ content and Na+, K+ -ATPase activity. All values 
are expressed as the mean ± SEM. The total cerebral cortical N a + and K+ content 
and N a +, K+ -ATPase activity of vehicle-treated controls and PHT-treated animals 
is represented by the stippled (controls) and open (PHT-treated) bars. Hatched 
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and although enzymic activity was still inhibited, no significant changes in tissue 
electrolytes (Na+, and K+) were observed. Na+, K+-ATPase activity was not 
significantly affected following chronic PHT treatment (bid and qid for 7 days). In 
contrast to the acute effect, total tissue Na+ was significantly reduced by both 
twice daily and four times daily PHT administration. These effects were observed 
in the absence of any measurable effect on whole homogenate Na+, K+-ATPase 
activity. 
As shown in Fig. 5, the cerebral cortical Na+, K+-ATPase activity of neonatal 
rats was maximally inhibited 2 hours after a single dose of PHT (20 mg/kg, ip). 
This figure also demonstrates the inverse relationship between Na+, K+ -ATPase 
activity, and Na+i concentration. The concentration of Na+i increased rapidly 
with increasing inhibition of Na+, K+-ATPase. Four hours after a single dose, the 
activity of Na+, K+-ATPase and the concentration of Na+i were approaching pre-
drug levels. As also shown in Fig. 5, the activity of Ca++, Mg++ -ATPase was 
increased over 2-fold 15 min after a acute dose of PHT (20 mg/kg). The activity 
of this enzyme was also found to be elevated 240 min after a similar dose. 
Between these two extremes of the time curve, Ca ++, Mg++ -ATPase activity 
remained elevated but was not statistically different from vehicle-treated 
controls as shown in Fig. 5. 
The activity of Na+, K+ -ATPase was determined in several subcellular 
fractions of the cerebral cortex following chronic PHT treatment of adult rats (20 
mg/kg, ip, qid for 7 days). As shown in Fig. 6, no change in whole homogenate or 
microsomal enzymic activity was observed with this treatment. A significant 
increase in both myelin (glial product) and mitochondrial Na+, K+ -ATPase activity 
was observed, and although not statistically different from controls, a 20% 
inhibition of the synaptosomal (neuronal) enzyme was seen following this 
treatment (20 mg/kg, ip, qid for 7 days). 
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Fig. 5. Time-effect of PHT on the activities of cerebral cortical Na+, K+- and 
Ca++, Mg++-ATPase, and the concentration of Na+i in the neonatal rat. At 
various times after a single dose of PHT (20 mg/kg, ip), neonatal animals were 
sacrificed, and the cerebral cortex removed. Enzymic activity (nM Pi/mg 
Protein/min) and Na+i (meq/l cell water) concentration was determined according 
to the procedures outlined in the methods. 
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Fig. 6. Effect of chronic PHT treatment on the subcellular activity of Na+, K+-
ATPase. Adult male rats were administered PHT (20 mg/kg, ip) four times a day 
for 7 days. Two hours after the last dose, animals were sacrificed, perfused with 
0.32 M sucrose, and cerebral cortex removed as outlined in the methods. 
Subcellular fractions obtained by sucrose density centrifugation (Gray and 
Whitaker, 1972) were assayed for Na +, K+ -ATPase activity according to the 
procedures outlined in the methods. All values are expressed as the mean ± SEM. 
Subcellular Na+, K+-ATPase activity vehicle-treated controls and PHT-treated 
animals is represented by the stippled (controls) and open (PHT-treated) bars. 
Hatched bars represent the percent change from control following PHT-
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As illustrated in Fig. 7, the cerebral cortex subcellular fractions of un-
treated adult rats contained measurable Ca++, Mg++ -ATPase activity. In contrast 
to its acute effect at postnatal day 3 (Fig. 5), chronic PHT (20 mg/kg, ip, qid for 7 
days) significantly reduced the activity of this enzyme in all subcellular fractions 
except the mitochondrial, in which no change in enzymic activity was observed. 
The effects of PHT on anion homeostasis as measured by changes in CI-
content, HC03 --ATPase activity, and carbonic anhydrase activity of the cerebral 
cortex are summarized in Fig. S. The acute administration of PHT to neonatal 
rats produced a significant increase in cerebral cortical Cl- content (Fig. SA). 
The Cl- content of adult rat cerebral cortex was not significantly affected by 
either acute or chronic (bid or qid) PHT administration. Cerebral cortical HC03--
ATPase activity was increased 2-fold following acute administration of PHT to 
neonatal animals (SB), and was increased 5S96 above control values following 
chronic (bid for 7 days) PHT-treatment of adult rats. No change in the activity of 
HC03 --ATPase was observed in the whole homogenate fractions of cerebral 
cortices obtained from animals treated chronically (20 mg/kg, ip, qid for 7 days). 
In these same animals, however, a significant increase in mitochondrial- (7296) and 
myelin- (37896) associated HC03 --ATPase activity was observed (Fig. 9). 
The effect of PHT on the activity of carbonic anhydrase was not determined 
in neonatal animals since little carbonic anhydrase activity is present at this age. 
The effect of PHT on the carbonic anhydrase activity of the cerebral cortex was 
dependent in-part on the duration of exposure as shown in Fig. SC. Acutely, PHT 
significantly decreased the activity of this enzyme whereas, chronically PHT 
increased enzymic activity in a dose-related manner. 
The effects of chronic PHT-treatment on glial cell proliferation (DNA 
content) and carbonic anhydrase activity are summarized in Fig. 10. In a dose-
related manner, the activity of the glial enzyme carbonic anhydrase (top) was 
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Fig. 7. Effect of chronic PHT-treatment on the subcellular activity of Ca++, 
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Fig. 8. Effect of acute and chronic PHT treatment on neonatal and adult rat 
cerebral cortical Cl-content, and the activity of HC0 3--ATPase and carbonic 
anhydrase. All values are expressed as the mean t SEM. The cerebral cortical CI-
content, HC03 --ATPase, and carbonic anhydrase activity vehicle-treated controls 
and PHT-treated (20 mg/kg, ip) animals are represented by the open (controls) and 
hatched (PHT-treated) bars. Stippled bars represent the percent change from 
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Fig. 9. Effect of chronic PHT treatment on the subcellular activity of Heo3--
ATPase. See legend to Fig. 6 for explanation. 
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Fig. 10. Effect of chronic PHT treatment on cerebral cortical carbonic anhydrase 
activity and DNA content of the adult rat. All values are expressed as the mean ± 
SEM. The absolute activity of CA (units/gm tissue) (top) and DNA content (ug/mg 
tissue) (bottom) for vehicle treated controls and PHT-treated animals is 
represented by the stippled (controls) and open (PHT-treated) bars. Hatched bars 
represent the percent change from control following PHT-treatment. (* p < 0.05). 
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increased 20% (bid) and 30% (qid) following chronic PHT-treatment. In a similar 
manner, the cerebral cortex DNA content (bottom) was increased 1096 (bid) and 
2096 (qid) with chronic PHT-treatment. 
The effect of chronic PHT-treatment on the subcellular activity of carbonic 
anhydrase is summarized in Fig. 11. As shown in this figure, the supernatant 
fraction contained the highest, and the microsomal fraction the lowest activity of 
carbonic anhydrase (units/mg protein). Both treatment schedules (bid and qid for 
7 days) increased carbonic anhydrase activity of the whole homogenate, and this 
increase was apparently the result of a specific increase (7596) in the membrane 
bound (microsomal) fraction. PHT produced no change in the activity of the 
supernatant fraction of carbonic anhydrase. 
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Fig. 11. Effect of chronic PHT treatment on the subcellular activity of carbonic 
anhydrase. See legend to Fig. 6 for explanation. 
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DISCUSSION 
Three-day old rats are an excellent model for studying in vivo the effects of 
a drug on neurons, since the brain at this age is comprised primarily of neurons 
and essentially no functional glial cells. The marked inhibition of Na+, K+-ATPase 
and the subsequent increase in total N a +, and decrease in total K+ (Fig. 4) after an 
acute dose of PHT given at this age reflects a direct action on neurons. The time 
course of the effect of PHT on Na+i concentration and Na+, K+-ATPase activity 
(Fig. 5) clearly illustrates that its inhibitory effect on the Na+, K+-ATPase 
enzyme was not compensatory to a decrease in Na+i' since at no time was the 
concentration of Na+i found to be lower than control. An increase in total Na+ of 
the magnitude shown in this figure, accompanied by a decrease in total K+, would 
be expected to produce a substantial depolarization of the neuronal membrane. 
Because both anatomical and biochemical evidence suggest that cerebral and 
cerebellar inhibitory circuits are poorly developed at this age, depolarization of 
neurons would lead not to protection against, but enhancement of seizure activity, 
whereas in adult animals, PHT possesses anticonvulsant activity by virtue of its 
ability to depolarize (stimulate) the now predominating inhibitory pathways. 
These data provide not only an explanation of PHT's excitatory effects that have 
been observed in neonatal animals (Vernadakis and Woodbury, 1969) and adult 
animals (Gruber et al., 1940) and human patients (Glaser, 1974; Lascelles et al., 
1970; Levy, 1965; Patel and Crichton, 1968; Roseman, 1961; Schreiner, 1958; 
Troupin and Ojemann, 1975) with high doses, but when extrapolated to adults, 
provides new information pertaining to its often controversial mechanism of 
action. 
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Support for this conclusion comes in part from studies described in the 
present report demonstrating that PHT when administered to adult rats in doses 
greater than 40 mg/kg, increased the seizure duration and the time spent in tonic 
hindlimb extension relative to the effects of PHT observed at 20 mg/kg (Fig. 2). 
Furthermore, doses greater than 40 mg/kg decreased the time spent in hindlimb 
fiexion and increased the E/F ratio. These effects are all consistent with 
enhanced excitability. In addition, it was demonstrated as early as 1941 by 
Goodman and Lih that PHT in large acute doses intensified the convulsive 
response of rodents to pentylenetetrazol. This observation has been subsequently 
confirmed and extended by Stone and Javid (1982). These investigators, reported 
that at 40 mg/kg, PHT enhanced the convulsive actions of both picrotoxin and 
bicuculline. That PHT is an excitatory drug is further suggested by the findings 
that it enhances the seizure activity of animals given strychnine, and of animals 
undergoing CO2 withdrawal seizures (see Woodbury 1980a and 1982 for discussion). 
PHT has been previously demonstrated to increase epithelial cell (toad 
bladder, frog skin, choroid plexus and glial cells) N a + - K+ -transport (Watson and 
Woodbury, 1972 and 1973; Carroll and Pratley, 1970; DeSousa and Grosso, 1973; 
Riddle et al., 1975; and Johanson and Smith 1977) and thus decrease Na+i and 
increase K+i• Since this effect is opposite that described above for neurons, it 
might be anticipated that the effect of PHT, when administered to an adult rat 
whose neuropil is comprised of both functional neurons and glia would be lessened 
or even completely attenuated. Although the acute administration of PHT to 
adult rats was found to inhibit Na +, K+ -ATPase (Fig. 4), the magnitude of its 
effect was much less than that observed in 3-day-old animals. The effect of PHT 
to inhibit N a +, K+ -ATPase was completely attenuated by prolonged administration 
(twice daily and 4 times a day treatment for 7 days). Despite no observable 
change in the activity of Na+, K+-ATPase, both chronic treatment regimens 
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significantly reduced the N a + content of the CNS (Fig. 4). A decrease in total 
Na+ without any change in enzyme activity would suggest that PHT is decreasing 
membrane permeability to Na+ by blocking Na+ channels. This is however, 
unlikely in the brain, since radioactive sodium turnover has been previously 
reported to be increased rather than decreased, a finding suggesting that N a + 
transport or efflux was increased (Woodbury, 1955). Thus, in adult rats, it would 
appear that chronic PHT enhances the activity or increases the synthesis of Na+, 
K+ -ATPase in glial cells, and this increased activity masks the continuing 
inhibition of this enzyme in neurons. The end effect of this apparent differential 
action on neuronal and glial cell Na+, K+-ATPase, is refected by no net change in 
whole homogenate enzymic activity. 
That PHT is differentially affecting neuronal and glial cells is supported by 
enzyme studies conducted on subcellular cerebral cortical fractions obtained from 
rats treated chronically 4 times a day for 7 days (Fig. 6). Although there was no 
change in whole homogenate or microsomal Na+, K+-ATPase activity, a 
significant increase in myelin (a glial product) ATPase activity was observed. In 
contrast, a 2096 decrease in the activity of this enzyme was observed in the 
synaptosomal (neuronal) fraction. These results suggest that even with chronic 
treatment, PHT continues to inhibit the neuronal enzyme but that this effect can 
be masked in the whole homogenate by its effect to enhance differentially the 
glial Na+, K+ -ATPase. 
PHT's ability to enhance glial cell Na+, K+-ATPase activity could result 
from either a direct effect on the glial enzyme or indirectly through its action to 
depolarize neuronal cells. As discussed in the following report (this issue) we have 
demonstrated that both acute and chronic PHT treatment of primary glial cultures 
directly increased glial Na +, K+ -ATPase activity. However, it is very probable 
that an increase in ECF K+ (K+ 0) concentration resulting from PHT's direct 
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inhibitory effect on neuronal Na+, K+-ATPase is stimulating the ATPase enzyme 
of glial cells. Ultimately, by increasing the activity of glial Na+, K+-ATPase, 
PHT provides the CNS with an enhanced ability to regulate K+ o. As discussed in 
the following report, this effect may prove to be very important in understanding 
the ability of PHT to prevent the spread (ictal transition) from a seizure focus. 
From these studies, it is apparent that a maJority of the discrepancies in the 
literature with regard to the effects of PHT on Na+, K+-ATPase activity in adults 
(see Woodbury, 1980a, for review) can be explained by a paucity of studies on both 
subcellular fractions of brain and isolated glia, and during ontogenesis of the 
nervous syste m. 
Carbonic anhydrase has a central role in the co-operative metabolism of 
neurons and closely contacting glia during regulation of anion and acid-base 
metabolism of brain cells, interstitial and cerebrospinal fluids. It is located 
exclusively in glia and choroid plexus (Giacobini, 1961; Korhonen et al., 1964; 
Rose, 1967; Tower and Young, 1973) but depends for its substrates on metabolites 
that are mostly generated and released during neuronal discharge. Bicarbonate-
stimulated ATPase in a similar manner depends for its substrate on the activity of 
carbonic anhydrase (CA) which catalyses the following reation: (C02 + H20 CA 
H2C03 ~ HC03 - + H+). Since both enzymes are dependent in part on neuronal ~ 
activity, it reasons that a change in neuronal excitability would be reflected 
biochemically by a change in their activities. 
In the present report, cerebral cortical carbonic anhydrase activity was 
significantly reduced by acute PHT-treatment (Fig. 8). In contrast, chronic 
administration of PHT increased the activity of carbonic anhydrase in the whole 
homogenate of the cerebral cortex (Fig. 8). Bicarbonate-ATPase activity was also 
increased in the whole homogenate of cerebral cortex following twice a day 
treatment for 7 days, but was not affected by the 4 times a day dosing schedule 
42 
(Fig. 8). Although no change was observed in the whole homogenate, a significant 
increase was found in the myelin and mitochondrial fractions (Fig. 9). These 
results illustrate the integral relationship that exists between carbonic anhydrase 
and HC03--ATPase. The decreased carbonic anhydrase activity observed 
following acute PHT administration would, like acetazolamide, cause CO 2 to back 
up in neurons and produce an anticonvulsant effect. Carbonic anhydrase activity 
in several systems appears to be mediated at least in part by a cyclic AMP 
induced phosphorylation of carbonic anhydrase (N arumi and Miyamoto, 1974; 
Narumi et al., 1978; Church et al., 1980). From this it follows that the acute 
effect of PHT on this enzyme is probably related to its well-established ability to 
inhibit calcium-dependent phosphorylation of specific brain proteins (DeLorenzo 
and Glaser, 1976; DeLorenzo et al., 1977). As with acetazolamide, tolerance to 
the inhibitory effect of PHT on carbonic anhydrase develops as suggested by the 
significant increase in activity of this enzyme following chronic PHT-treatment 
(Figs. 8 and 10). This effect was accompanied by increased HC03 --ATPase 
activity in the whole homogenate, and in the myelin and mitochondrial subcellular 
fractions following either twice- or four-times daily treatment. These results 
further illustrate the intimate relationship that exists between these 2 enzymes. 
Carbonic anhydrase, along with the mitochondrial enzyme HC03 --ATPase 
(Kimelberg and Bourke, 1973) are both intimately involved in the regulation of 
HC03 --CI- transport across glial cells and mitochondrial membranes. 
Intracellular cr is also thought to be regulated by a CI--HC03 - exchange 
mechanism in which extracellular CI- eXChanges with intracellular HC03 --
(Kimelberg et al., 1979), and it is through this mechanism that the stilbene 
derivative SITS inhibits the uptake of CI- into glial cells. Inhibition of CI-
transport into glial cells by low doses of the monovalent anions, perchlorate and 
thiocyanate which inhibit HC03--ATPase and carbonic anhydrase, results in an 
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increased brain excitability (increased ElF ratio). Furthermore, in higher doses it 
cause seizures, that can be enhanced by acetazolamide (Woodbury and Kemp, 
1977). Thus, it is evident that glial cell active Cl- transport is involved in 
regulation of brain excitability and that carbonic anhydrase and HC0 3 --ATPase 
play an important role in mediation of this process. Indeed the data in Fig. 8 
suggest a relationship between cerebral cortical Cl- content and the activities of 
these two enzymes. Experiments to document this are now being conducted in 
this laboratory. That carbonic anhydrase activity is related to brain excitability is 
demonstrated by the data on audiogenic seizure mice (Woodbury et al., 1983). As 
illustrated in this report, the intensity of the audiogenic seizure, was directly 
related to the activity of carbonic anhydrase. Furthermore, Engstrom et ale 
(1983) have recently demonstrated that in audiogenic seizure susceptible DBA 
mice, the cerebral and cerebellar cortical carbonic anhydrase activity is highest 
at postnatal day 21, the period when they are maximally susceptible to audiogenic 
seizures. Thus, it appears that the increased activity of these two enzymes 
observed in various cerebral tissues of the audiogenic susceptible mouse were 
compensatory to increased levels of neuronal activity. 
In neonatal animals, a significant increase in the cerebral cortical activity 
of HC03 --ATPase was observed 2 hours after an acute dose of PHT (Fig. 8). This 
observation, adds further support to the hypothesis that PHT is enhancing neuronal 
activity, since, (as discussed above) the substrate for this enzyme (HC03 -) is 
primarily derived from conversion of the neuronal waste product CO2 to HC03-
and H+. In the absence of any significant carbonic anhydrase activity in the 
cerebral cortex of control animals at postnatal day 3, CO2 would build up and 
HC03- would be formed through the much slower uncatalyzed conversion of CO2-
Bicarbonate ATPase has also been postulated to be an important enzyme in 
biotin catalyzed "C02"-fixation reactions of the mitochondria. These reactions 
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are important for the synthesis of fatty acids for myelin formation, synthesis of 
neurotransmitter precursors, such as oxaloacetate, a precursor of aspartate and 
which is also converted in the Kreb's cycle to alpha-ketoglutarate, a precursor of 
glutamate (Woodbury, 1980b). Therefore, through an activation of both HC03--
ATPase and carbonic anhydrase, PHT enhances the ability of the CNS to regulate 
anion homeostasis, cell pH, and "C02"-fixation reactions, all metabolic functions 
maintained under tight control in order that optimal conditions for proper enzymic 
functioning be maintained. 
Calcium concentration in the cell is regulated through both a Ca ++:N a + 
counter-transport process and the enzyme Ca++, Mg++-ATPase (for discussion see 
Latzkovits and Fajszi, 1982). Thus, when the concentration of Ca ++ i increases 
above physiological levels, cytosolic Ca ++ exchanges with extracellular N a +, and 
also activates an active extrusion mechanism (Ca++, Mg++ -ATPase) in a 
compensatory attempt to decrease Ca ++ i concentrations. When Ca ++ i is 
decreased, the reverse is true, that is, exchange of Na + i for Ca ++ 0 and a inhibition 
of the Ca++, Mg++-ATPase. Therefore, it follows that the increased activity of 
Ca++, Mg++-ATPase observed after acute treatment of neonatal animals (Fig. 5) is 
compensatory to an increased Ca ++ i. It can be further reasoned that the increase 
in Na+i observed in these same animals activates a compensatory Na+:Ca++ 
counter-transport process which would decrease Na+i. This has the effect to 
increase ca++i' which also activates Ca++, Mg++-ATPase. In contrast to the 
acute effect of PHT, the data presented in Fig. 7 suggest that chronic PHT-
treatment of adult rats decreases the Ca ++ i concentration of the cerebral 
cortex. This conclusion is supported by the observation that Ca ++, Mg ++ -ATPase 
activity was decreased in all subcellular fractions except the mitochondria. 
Additional studies are being conducted to determine whether this enzymatic 
decrease is secondary to a decreased Ca ++ -flux (Sohn and Ferrendelli, 1973 and 
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1976), or is a direct effect of PHT to inhibit this enzyme. 
In the present report, we have examined the acute and chronic effects of 
PHT on several parameters of cation and anion homeostasis in the intact cerebral 
cortex of neonatal and adult rats. In the neonate (postnatal day 3) PHT produced 
marked and significant changes in Na+, K+-, Ca++, Mg++-, and HC03--ATPase. 
These effects when correlated with tissue electrolyte content are consistent with 
the hypothesis that PHT is an excitatory drug. In the adult rat, when the CNS is 
comprised of both functional neurons and glia, similar changes of a lesser 
magnitude were observed following acute PHT administration. These changes 
were further attenuated by chronic PHT-treatment, and discernable changes in 
enzymic activity could only be detected in the subcellular fractions of the 
cerebral cortex. Inhibition of the synaptosomal-, and stimulation of the myelin-
associated N a +, K+'-ATPase strongly suggest that chronic PHT is differentially 
affecting neuronal and glial cell membranes. In addition, the present results 
suggest that PHT by increasing neuronal activity, indirectly enhances both anion 
and acid-base metabolism within the CNS. 
The studies conducted in the present report support the hypothesis that PHT 
possesses anticonvulsant activity by virtue of its ability to stimulate 
predominating inhibitory systems of the mature brain. Furthermore, by 
stimulating glial cell cation and anion systems, PHT provides the CNS with an 
enhanced ability to regulate the ionic and acid-base environment of the intact 
eNS, thereby limiting the spread of seizure activity. These effects on active 
transport processes of neuronal and glial cells were observed at the anticonvulsant 
dose of 20 mg/kg, which produces blood levels of approximately 10 ug/ml 
(unpublished observations). Additional in vitro stUdies conducted on primary 
astroglial cultures have demonstrated significant effects of PHT on the activity of 
Na+, K+-ATPase and the membrane potential at concentrations of 10-6 and 10-5 
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M PHT (for discussion see following report). MacDonald et ale (1983) have 
recently demonstrated that these concentrations possess significant 
anticonvulsant activity in cultured spinal and cerebral cortical neurons, and are 
much lower than the levels required to block both N a + and Ca ++ influx. Since the 
effects on neuronal and glial active transport processes described in the present 
report were observed at similar concentrations, they appear to be equally 
important to the mechanism of the anticonvulsant action of PHT. 
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PART TWO 
EFFECTS OF PHENYTOIN ON PRIMARY GLIAL CELL CULTURES 
INTRODUCTION 
The mechanism of action of PHT, as with most anticonvulsant agents, 
remains uncertain despite its continued wide-spread use in the treatment of 
convulsive disorders. PHT has been observed to exert an effect on many different 
systems thereby making it difficult to formulate a single mechanism of action. 
For example, it decreases both inward sodium (Na+) (Lipicky et al., 1972) and 
calcium (Ca++) (Sohn and Ferrendelli, 1973; Sohn and Ferrendelli, 1976) fluxes 
across biological membranes as well as increases mucosal membrane permeability 
of epithelial cells to Na+ (Watson and Woodbury, 1972; Watson and Woodbury, 
1973). In addition, PHT exerts numerous effects on neurotransmitter synthesis 
and release most of which are presumably the result of its predominate action to 
alter Na+ and Ca++ homeostasis (For reviews of PHT's proposed mechanism of 
action see Woodbury, 1982 and Woodbury et al., 1983) 
Previous in vivo studies (see preceeding paper) have demonstrated that 
chronic administration of PHT to adult rats increases cerebral cortical DNA 
content, carbonic anhydrase activity, and myelin-associated Na+, K+ -ATPase 
activity (White et al., 1983). These observations suggest that PHT is capable of 
significant interaction with glial cells. That this may be functionally important in 
understanding PHT's mechanism of action is suggested by a growing body of 
evidence supporting a primary role for glial cells in the homeostatic regulation of 
extracellular K+ (K+ 0) as well as other neuroactive substances including 
glutamate, aspartate, and GABA (Hertz, 1979 and 1982). As originally proposed in 
1970 by Pollen and Trachtenberg, disease states, such as epilepsy, that are 
characterized by abnormal neuronal discharges might result from, or be 
aggravated by the absence or failure of the glial buffering system. 
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With cell culture techniques, it has become possible to grow various CNS cell 
types for long periods of time. This allows the investigator to study in isolation 
not only the effects of drugs on neuronal and glial cells, but also provides insight 
into the compartmentation of electrolytes, enzymes and amino acid metabolism. 
Extensive biochemical, morphological and histochemical studies suggest that 
primary cultures of newborn rat brain retain a remarkable capability to 
differentiate into cells closely resembling astrocytes in vivo. In addition, 
numerous examples exist in which in vitro development of glial cells closely 
parallels in vivo development. For example, three enzymes involved in cation and 
anion transport in the CNS (Na+, K+-ATPase, HC03--ATPase, and carbonic 
anhydrase) have all been demonstrated to exist and develop in vitro in a manner 
approximating in vivo maturation (Kimelberg et al., 1978). Although drawbacks do 
remain, the use of primary cultures of new born rat brain as a model for normal 
astrocytes does provide obvious advantages when studying in isolation, the effects 
of drugs for the purpose of identifying and separating specific drug actions 
attributable to a particular cell type. 
The studies conducted in the present investigation were designed to examine 
the hypothesis that PHT, by increasing the responsiveness and/or proliferation of 
glial cells is capable of providing the CNS with an enhanced ability to regulate 
ionic and acid-base homeostasis within the brain ECF, thereby limiting the spread 
of seizure activity. We have attempted to provide direct evidence for this 
hypothesis by examining changes in the concentration of intracellular K+, the 
activity of enzymes involved in cation and anion transport (Na+, K+ -ATPase, 
Ca++, Mg++-ATPase, and HC03--ATPase) and the transmembrane potential of 
primary a.stroglial cultures following acute and chronic exposure to micromolar 
concentrations of PHT. 
METHODS AND PROCEDURES 
Animals 
Pregnant female rats of the Sprague-Dawley strain were obtained from an in-
house breeding colony, and served as the source for neonatal pups used in all 
experiments. All rats were housed in individual cages in a temperature and 
humidity controlled environment, and allowed free access to Purina Rat Chow and 
water ad libitum. Lighting was maintained on a 12 hour on and a 12 hour off cycle 
(on 0800, off 2000 hours). 
Cell Culture 
Primary cell cultures of non-neuronal cells were started from cerebral 
cortical tissue of 3-day-old rat pups using a method modified from Booher and 
Sensenbrenner (1972) and Kimelberg et ale (1978). Brieny, under sterile 
conditions, the brains of 3-day-old Sprague-Dawley rats were removed, the 
cerebral cortex dissected free, and the meninges carefully removed. Tissues were 
then minced by razor blades on a tenon plate and placed in prewarmed (370 C) 
Ca++ -free Dulbecco's phosphate buffered saline (PBS) containing 0.25% trypsin 
(10cc/8 brains). Tissues were digested by stirring with trypsin for 10 min in a 
sterile polyethylene beaker. One ml of rabbit serum was then added to 15 ml of 
digest fluid to inactivate the trypsin. At this time, undigested debris was removed 
with a pipette, and separated cells were pelleted and resuspended 3 times in basal 
minimal essential (Eagle's) medium supplemented with 1096 fetal bovine serum, 
Penicillin (100,000 U/1), Streptomycin (100,000 meg/I), and Fungizone (250 
meg/I). Cells obtained from 8 cortices were then plated into thirty 60 x 15 mm 
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Falcon disposable plastic culture dishes. Culture medium was changed 24 hours 
after the initial plating, and twice a week thereafter. Cultures were grown at 
370 C in a 95% air/596 C02 humidified incubator. Cultures were maintained for 14 
days under these conditions. Beginning on day 14, one-half of the cultures were 
exposed to medium supplemented with 0.25 mM Dibutyryl cyclic Monophosphate 
(DBcAMP) for an additional 1-2 weeks. Chronic treatment with DBcAMP 
transf orms normal fiat polygonal cells into cells possessing abundant processes 
that morphologically resemble mature astrocytes (Lim et al., 1973; Moonen et al., 
1975; Sensenbrenner et al., 1977; and Walz and Hertz, 1982). In light of this, it 
was of interest to examine the effect of PHT on both "undifferentiated" fiat cells 
and "DBcAMP-differentiated" cells. Medium supplemented with DBcAMP was 
prepared fresh at the time of each medium change. At the completion of the 
experiment, cells were washed 3 times with 0.32 M sucrose and placed in the 
freezer (-200 C) until further analysis could be performed. 
Drug Treatment 
Stock drug solutions were made by dissolving sufficient PHT into either 95% 
ETOH or Dimethyl Sulfoxide (DMSO) to give concentrations of 0.5, 5.0, and 50 mM 
PHT in vehicle. At the time of the experiment, these solutions were then diluted 
1:5000 with culture medium to produce a final concentration of 0.1, 1.0, and 10 
uM PHT in medium containing 0.02% vehicle. 
Cultures grown in the presence or absence of DBcAMP were treated acutely 
for 2 hours and chronically for 4 days with various concentrations of PHT. Results 
of these studies were compared to control cells which were exposed for a similar 
period of time to medium plus vehicle (0.0296 ETOH or DMSO). 
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Enzyme Assays 
On the day of determination, cells still attached to the dish were covered 
with 2 ml of ice cold distilled water, scraped free from the plastic surface with a 
rubber policeman, and transferred to a glass homogenizing tube fitted with a 
teflon pestle. After homogenizing (ten strokes of the pestle), cells were diluted to 
a final volume of 5 to 10 ml with ice cold distilled water. This solution was then 
used for determination of enzyme activities, DNA and protein contents as 
described in the preceeding paper. 
The effect of K+ 0 concentration on Na+, K+-ATPase activity was determined 
following both acute and chronic exposure of glial cells to various doses of PHT. 
In these studies, Na+, K+ -ATPase activity was determined in the presence of 
buffer containing different K+ 0 (1-20 mM) concentrations. 
Determination of Intracellular K+ 
and PNa/PK Ratio. 
Concentration of K+i and the ratio of PNa/PK following various treatments 
were estimated from a plot of the exponent of membrane potential/SO against K+ 0 
concentration as described by J. W. Woodbury (1982). The PNa/PK ratio obtained 
from the potassium depolarization curve is a reliable estimate of Na+ and K+ 
permeability across cell membranes. 
Measurement of transmembrane potentials 
Technical difficulty in measuring the membrane potential of flat monolayer 
cells grown on plastic culture dishes necessitated that cells be replated onto 
collagen-coated culture dishes three days prior to measurement. This period of 
time allowed the transferred cells to regain their normal morphology. The 
presence of the collagen layer also permitted greater numbers of cells to be 
impaled with less breakage of microelectrode tips. With this method, the effects 
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of acute and chronic PHT on the Em of both fiat and morphologically 
differentiated glial cells (DBcAMP-treated) were investigated. 
Collagen-coated dishes were prepared by mixing 0.5 ml of sterile purified 
collagen solution (Vitrogen 100 from Flow Laboratories, McLean, Virginia) and 1 
ml of culture medium in a 35 x 10 mm Falcon tissue culture dish. Dishes were 
warmed at 370 C for approximately 30 min until a collagen gel layer securely 
attached to the bottom of the culture dish was formed. Glial cells that were 
successfully grown in culture for various periods of time (14-28 days) were then 
harvested by adding 2 ml of 0.12596 trypsin in Ca++ -free PBS to one 60 x 15 mm 
culture dish. After 30 min, the cells were scraped off the dish with a rubber 
policeman, transferred to a sterile centrifuge 'tube containing 0.5-1.0 ml of rabbit 
serum, and centrifuged at 1500 rpm for 5 min. The cell pellet was washed 3 times 
with culture medium to eliminate the inactivated trypsin and rabbit serum. The 
final pellet was resuspended in 4 ml of culture medium. One ml of the final cell 
suspension and 1 ml of culture medium were then plated directly onto a collagen-
gel-coated culture dish and mixed well before placing in the incubator. Membrane 
potentials were measured 3 days after replating onto collagen. 
Microelectrodes were constructed from Corning 7740 capillary tubing (o.d. 
1.2 mm, i.d. 0.9 mm) and were drawn by a Narishige PE-2 vertical electrode 
puller. The tip diameter was approximately 1 urn with a resistance of 10 to 20 
megohms when filled with 3 M KCI. Microelectrodes were connected to an 
electrometer with negative capacitance compensation, and the output was 
simultaneously displayed on a Hewlett-Packard 132H oscilloscope and a Beckman 
dynograph. The microelectrode was gradually advanced into the cell body of each 
cultured glial cell with a Brinkman micromanipulator attached to the slide stage 
of an Olympus phase-contrast microscope. 
On the day of the experiment, culture medium was replaced with a HEPES 
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buffered iso-osmotic medium, consisting of the following components (in 
mmol/l): NaCI 122; KCI 3; CaC12 1.3; MgS04 1.2; KH2P04 1.2; HEPES (titrated 
to 7.4 with NaOH) 20; NaHC03 10; glucose 10, and sucrose 60. 
The effects of acute and chronic PHT treatment on the membrane potential 
and the PNa/PK ratio of cultured glial cells grown in the presence and absence of 
DBcAMP were determined. The effects of K+ 0 concentrations (3-90 mmol/l) on 
the potential of chronic PHT-treated glial cells were also determined. In these 
experiments, Na+ 0 was reciprocally adjusted to maintain the osmolality when K+ 0 
concentration was varied. 
The acute effect of PHT on the membrane potential of 17-day cultures grown 
in the absence and presence of DBcAMP (0.25 mM for 3 days) was determined. 
Cells were incubated at 370 C for 60 min with HEPES buffer containing a final K+ 0 
concentration of 5.4 mM. After several control impalements were made, the 
same dish was incubated for an additional 60 min with HEPES buffer containing 
various concentrations (1 x 10-6 to 1 x 10-4 M) of PHT. The Em of cells 
chronically exposed to PHT (10-5 M) for 4 days was also determined at several 
K+ 0 concentrations (3-90 mM). 
RESULTS 
Culture Growth and Morphology. 
Primary cultures of glial cells grown in the absence of DBcAMP for 28 days 
were composed of a monolayer of fiat polygonal cells that exhibited little or no 
process extension, and reached confluency at or near 2 weeks. In addition to the 
predominate fiat cell, it was common to find 3 additional cell types firmly 
attached to the dish. These included, large phase-bright cells with round cell 
bodies, small phase-dark process-bearing cells, and ciliated epithelial cells. 
Figure 12A represents an average culture with a few dispersed phase-bright cells 
on a monolayer of predominate fiat cells. 
Figure 12B illustrates the marked morphological changes induced in primary 
cerebral cultures when they were chronically exposed (14 days) to medium 
containing 0.25 mM DBcAMP beginning on culture day 14. It can be seen from 
this figure that process extension and rounding of the cell body are characteristic 
features produced by this cyclic nucleotide derivative. No differences in 
morphology between control and PHT-treated (either acute or chronic) cells were 
observed under phase contrast microscopy. 
Chronic exposure to 0.25 mM DBcAMP reduced the total protein (Fig. 13-top) 
and DNA content (Fig. 13-middle) of cultured glial cells by 1496 and 34% 
respecti vely. These large decreases in protein and DNA content were 
accompanied by significant cell differentiation as suggested by the 3796 increase 
in total protein/DNA ratio (Fig. 13-bottom). 
Chronic exposure to 10-5 M PHT for 4 days had little effect on the total 
protein and DNA content of cultured glial cells grown either in the presence or 
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Fig. 12. Phase contrast micrograph of cultured rat glial cells (x100). 
a. Control cells after 28 days in culture. This photomicrograph illustrates the 
cellular heterogeneity often found in primary glial cultures. Besides the 
predominate fiat cell, numerous phase bright and phase dark cells can also be seen 
in the average culture. 
b. Cultured glial cells cultivated in the presence of 0.25 mM DBcAMP for 14 
days. Note the extensive process extension and rounded cell body. These features 
are characteristically produced by this cyclic nucleotide derivative. 
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Fig. 13. The effect of chronic PHT treatment on the total protein (top) and DNA 
content (middle) and the protein/DNA ratio (bottom) of 4 week glial cultures. 
Beginning on culture day 24, cells grown in the absence (left) and presence (right) 
of 0.25 mM DBcAMP were treated with 1 x 10-5 M PHT for 4 days. Results 
represent the mean ± SEM of 10-11 samples obtained from 3 independent 
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absence of DBcAMP (Figs. 13-top and 13-middle). In addition, PHT had no 
significant effect on cell growth as estimated by the protein/DNA ratio shown in 
Fig. 13-bottom. 
Enzymic Activity 
The Na+, K+-ATPase activity of cultured cells was measured in the presence 
of increasing K+ 0 concentration following acute and chronic treatment with 
PHT. The results are expressed as a percentage of the enzyme activity obtained 
at a K+ 0 of 10 mM and are summarized in Fig. 14. Following acute exposure to 
10-6 M PHT (Fig. 14A), a significant activation of Na +, K+ -ATPase was observed 
at 20 mM K+ 0' but at all other K+ 0 concentrations, the activation pattern of 
control and PHT-treated cells was not statistically different. However, it is of 
interest to point out that in the presence of 10-6 M PHT, the resulting K+ 0 
activation curve was defined by two distinct peaks in enzyme activity. These 
peaks at 5 and 15 mM K+ 0 were markedly higher than were the corresponding 
peaks of control cells. In sharp contrast, the K+ 0 activation pattern of cells 
acutely exposed to 10-5 M PHT was characterized by one broad peak in enzyme 
activity that extended over a wide range of K+ 0 concentrations (5-15 mM). 
Na+, K+-ATPase activity of cultured glial cells was also measured in the 
presence of increasing K+ 0 following chronic exposure to similar concentrations of 
PHT for 4 days (Fig. 14B). In both control and treated cells, activation curves 
were characterized by 2 peaks in enzyme activity. The percent of enzyme 
acti vated at each K+ 0 concentration examined was higher in cells chronically 
exposed to PHT as compared to control cells. 
Membrane Potentials. 
The tracings in Fig. 15 illustrate the successful impalements of several 28-
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Fig. 14. Infuence of K+ on the N a +, K+ -ATPase activity of 22-26 day glial 
cultures acutely (A) and chronically (B) exposed to micromolar concentrations of 
PHT. Data are expressed in percent of activation of activities measured in the 




























Fig. 15. Membrane potential recordings from the successful impalement of 
control glial cells in culture. Three days prior to Em measurement, cells initially 
plated onto plastic culture dishes were replated onto collagen-coated culture 
dishes. Cells were impaled with 3 M KCl microelectrodes at the points indicated 
by the downward arrows. The upward arrows indicates the point of electrode 
withdrawal. All impalements were made at room temperature (24-250 C) at a K+ 0 
of 5.4 mM. The membrane potentials of the the 5 cells shown here were -33, -32, 
-40, -23, -25 mY, respectively. 





day-old cells. Upon impalement, stable negative potentials were recorded. In Fig. 
16, histograms of the membrane potentials of a group of 28-day-old cerebral 
cultures grown in the absence (lSA) and presence (lSC) of 0.25 mM DBcAMP are 
shown. Membrane potentials were recorded at room temperature at a K+ 0 
concentration of 5.4 mM. The mean potential for undifferentiated controls was 
-24 mV with a range of 57 mV (-4 to -61 mY) as shown in Fig. 16A. In addition to 
the marked morphological changes associated with chronic exposure to DBcAMP, 
a significant hyperpolarization (-13 mY) was also observed (Fig. 16C). 
The membrane of cultured glial cells grown in the absence and presence of 
DBcAMP and chronically exposed (4 days) to 10-5 M PHT was also hyperpolarized 
as compared to controls. Chronic PHT treatment of fiat undifferentiated cells 
resulted in a -12 mV increase in their Em as shown in Fig. lSB. Chronic PHT 
treatment also increased the Em of DBcAMP differentiated cells (Fig. 16D). 
However, its effect on these cells was of a lesser magnitude (-5 mY) than that 
observed when undifferentiated cells were exposed to a similar concentration of 
PHT (Fig. 15B). 
Effect of Acute Phenytoin on the 
Em of Glial Cells 
The acute (1 hour) effect of various concentrations of PHT on the Em of 17-
day-old cultured glial cells was determined at a K+ 0 of 5.4 mM. As shown in Fig. 
17, the effect of PHT on the Em was biphasic, characterized by membrane 
hyperpolarization at concentrations up to 1 x 10-5 M. Above this concentration, 
the membrane was depolarized (relative to the Em at 10-5 M PHT). When cells 
were exposed for 3 days to 0.25 mM DBcAMP, a similar biphasic effect of PHT 
was also observed (Fig. 17). In both control and DBcAMP treated cells, a peak 
hyperpolarization of 24 and 22.596 respectively was observed at 1 x 10-5 M PHT. 
Above this concentration, Em progressively returned to control values (Fig. 17). 
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Fig. 16. Histograms illustrating the distribution of cultured glial cell membrane 
potentials grown in the absence (A) and presence (e) of DBcAMP and chronically 
exposed to 10-5 M PHT (B and D). Membrane potential were recorded with 3 M 
Kel microelectrodes at room temperature (24-250 e) at a K+ 0 of 5.4 ent of 
activation of activities measured in the presence of 10 mM K+ (considered 
10096). • p<0.05 when compared to vehicle treated controls. 
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Fig. 17. Effect of acute PHT on the membrane potential of 17-day old cultured 
glial cells grown in the absence and presence of DBcAMP (0.25 mM for 3 days). 
Cells plated on collagen-coated culture dishes were exposed to various 
concentrations of PHT for 1 hour prior to Em measurement. Open bars represents 
cells grown in the absence of DBcAMP, and hatched bars represent cells grown in 
the presence of 0.25 mM DBcAMP for 3 days. Number in parenthesis represents 
the number of individual cells impaled at each point. * p < 0.05 when compared to 
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Effect of K+ Depolarization on the Em of 
cultured Glial Cells 
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The effects of increasing K+ 0 on the Em of 29-day-old cultured glial cells are 
shown in Fig. 18. In order to maintain a constant osmolality in the bathing 
solution and prevent swelling of cells, the N a + 0 of the buffer was reciprocally 
lowered as the K+ 0 was increased. A t all K+ 0 concentrations, the membrane 
potentials of cultured glial cells demonstrated a divergence from the 59 mV slope 
that is predicted by the N ernst equation for a perfect K+ electrode. 
Chronic PHT treatment produced no significant change in the slope of the 
K+ 0 depolarization curve when compared to cells grown in the absence (Fig. 18A) 
and presence of DBcAMP (Fig. 18B). However, as already demonstrated, the Em 
of cells chronically exposed to PHT was consistently higher (hyperpolarized) than 
that of the corresponding control at each K+ 0 concentration. 
Effect of DBcAMP on the Intracellular K+ Content 
and Enzyme Activity of Cultured Glial Cells 
In addition to the marked morphological and electrophysiological changes that 
were seen in primary glial cultures chronically exposed to DBcAMP, significant 
alterations in the activities of 3 major transport enzymes were observed (Figs. 19 
and 20). However, the K+i concentration and the PNa/PK ratio were not 
significantly changed (Figs. 21-top and 21-bottom). DBcAMP caused a 2-fold 
increase in the activities of, HCD3 - (Fig. 19), and N a +, K+ -ATPase (Fig. 20A), and 
a 2.5-fold increase in the activity of Ca ++, Mg ++ -ATPase (Fig. 20B), an enzyme 
involved in the translocation of Ca ++ i. 
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Fig. 18. Effect of chronic PHT treatment on the K+ o-induced depolarization of 
28-day old glial cells grown in the absence (A) and presence (B) of DBcAMP. 
Culture medium was replaced with HEPES buffered medium containing varying K+ 
concentrations. N a + concentration of the buffer was reciprocally changed as the 
K+ 0 was increased in order to maintain osmolality. The number of cells impaled 
at each K+ 0 concentration ranged between 23 and 41. Each value shown is the 


































28-0AY-OLD CULTURES GROWN IN THE PRESENCE OF 




3 30 90 
78 
Fig. 19. Effect of chronic PHT treatment on the activity of HC03 --ATPase. 
Beginning on culture day 24, glial cells grown in the absence (left) and presence 
(right) of DBcAMP were treated for 4 days with 1 x 10-5 M PHT. Chronic 
DBcAMP increased the activity of HC03 --ATPase 2-fold when compared to 
vehicle treated controls. PHT did not significantly affect the enzymic activity of 
either undifferentiated controls or DBcAMP-differentiated cells. Results 
represent the mean ± SEM of 10-11 samples obtained from 3 independent 























Fig. 20. Effect of chronic PHT treatment on the activities Na+, K+- and Ca++, 
Mg++ -ATPase. Four-week cultured glial cells grown in the absence (left) and 
presence (right) of DBcAMP were treated for 4 days with 10-5 M PHT beginning 
on culture day 24. The activity of both Na+, K+- (A) and Ca++, Mg++-ATPase (B) 
was increased 2- and 2.5-fold, respectively with DBcAMP treatment. In 
morphologically undifferentiated control cultures (left), chronic PHT treatment 
produced a 2-fold increase in the activity of Ca++, Mg++-ATPase, whereas in 
DBcAMP-differentiated cultures (right), chronic PHT treatment produced a 2-fold 
decrease in the activity of this enzyme. Results represent the mean ± SEM of lO-
II samples obtained from 2-3 independent experiments. * p< 0.05 when compared 
to respecti ve controls. ** p 0( 0.05 when compared to morphologically 


































Effect of PHT on the Intracellular K+ Content 
and Enzyme Activity of Cultured Glial Cells 
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As shown in the top portion of Fig. 21, the K+ i concentration of 
undifferentiated fiat cells was significantly elevated following their chronic 
exposure to 10-5 M PHT for 4 days; however, the PN a/PK ratio was not 
significantly altered (Fig. 21-bottom). There was no significant difference in the 
concentration of K+i , but the PNa/PK ratio was significantly reduceq following 
the chronic treatment of DBcAMP differentiated cells with 10-5 M PHT for 4 
days. 
Ca++, Mg++-ATPase was the only enzyme significantly affected by chronic 
PHT treatment (Fig. 20B). When compared to undifferentiated controls, its 
activity was increased almost 2-fold (8996) in PHT treated cells. In contrast, 
chronic PHT treatment of DBcAMP differentiated cells significantly inhibited 
Ca++, Mg++-ATPase (Fig. 20B). No change in the specific activity (nM inorganic 
phosphate/mg protein/min) of Na+, K+ - (Fig. 20A) or HC03 --ATPase (Fig. 19) was 
observed. Because the activity of Na+, K+-ATPase in these experiments was 
determined at only one K+ 0 concentration (K+ 0 = 5.0 mM), this figure is not 
directly comparable to Fig. 14 which illustrates the effect of PHT on enzyme 
activation rather than on specific activity. 
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Fig. 21. Effect of chronic PHT treatment on the K+i concentration (A) and the 
PN a/PK ratio (B) of 28-day glial cultures grown in the absence and presence of 
DBcAMP. The K+i (A) and PNa/PK (B) ratio were both determined from a plot of 
the exponent of -Em/SO against Na+ 0 concentration as described by J. W. 
Woodbury (1982). Chronic PHT increased the K+ i concentration (A) of 
undifferentiated controls without significantly affecting the PNa/PK ratio (B). 
Treatment of DBcAMP-differentiated cultures (right) significantly reduced the 
PNa/PK ratio (B-right) while only increasing the K+ i concentration slightly (A-


















Previously, we have demonstrated that the acute administration of PHT (20 
mg/kg) to 3-day-old rats significantly lowered Na+, K+ -ATPase activity, and 
consequently increased N a + i' and decreased K+ i of the cerebral and cerebellar 
cortices (White et al., 1983). Since the neuropil of the developing eNS is 
comprised primarily of nerve cells at this age, this observation reflects a direct 
interaction between PHT and neuronal cells. Several other in vivo observations 
including significant increases in cerebral cortex carbonic anhydrase activity, 
myelin-associated Na+, K+-ATPase activity, and DNA content have suggested that 
chronic PHT treatment of adult rats is capable of significant interaction with the 
glial regulatory system. In the present study, we have attempted to identify and 
characterize the in vitro effects of PHT on cultured neuroglial cells. In vitro 
studies on cultured glial cells provide one means whereby certain interpretational 
problems associated with the cellular heterogeneity of the intact CNS can be 
circum vented. 
Under two distinct culture conditions (medium supplemented with or without 
DBcAMP), we investigated the effect of acute and chronic PHT treatment on 
several biochemical and electrophysiological parameters of cultured glial cells. 
The total protein content of cultures exposed to 0.25 mM DBcAMP for 2 weeks 
beginning on culture day 14 was reduced (Fig. 13-top). Since cell division was 
reduced even further (Fig. 13-middle), the protein/DNA ratio which is an indirect 
measure of cell differentiation was significantly elevated above control cultures 
(Fig l3-bottom). However, it has been suggested by Sensenbrenner et ale (1980) 
that changes induced by DBcAMP represent a pathological phenomena rather than 
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a maturation process. Although it is yet to be resolved how closely DBcAMP-
differentiated cells resemble normal astrocytes, it was of interest to examine the 
biochemical and the electrophysiological eff ects of PHT on two distinct 
morphological cell types •. 
In the present report, Na+, K+ -ATPase activity was measured in the presence 
of varying concentrations of K+ 0 (Figs. 14A and 14B). The presence of 2 peaks in 
enzyme activity at 5 and 12.5 mM K+ 0 suggest that 2 distinct enzyme forms with 
diff erent kinetic characteristics are present in these cultures. Although the 
predominate cell type of primary astroglial cultures is the morphologically flat 
polygonal cell, considerable heterogeneity does exist, and it is quite common to 
find small phase-dark process-bearing cells growing in the average culture. These 
cells have been frequently observed by others, and have tentatively been 
identified both morphologically (McCarthy and DeVillis, 1980; Boot et al., 1981) and 
immunocytochemically (Bhat et al., 1981) as oligodendrocytes. Although additional 
studies are needed, it is quite possible that the lower enzyme peak at 5 mM K+ 0 
reflects the activation pattern of oligodendrocytes, whereas the higher peak 
between 12.5 and 20 mM is primarily astrocytic in origin. Consequently, such cell 
heterogeneity makes any conclusion regarding the possible presence of 2 enzyme 
forms extremely tenuous. 
More importantly, our present results indicate that glial cultures chronically 
treated with micromolar concentrations of PHT have increased their capacity to 
control elevated K+ o. As illustrated in Fig. 14B, the efficiency of glial N a +, K+-
A TPase was substantially enhanced over a wide-range of K+ o. The enhanced 
efficiency of PHT-treated cells at low K+ 0 would presumably prevent EeF K+ 
concentrations from rising much above normal levels during excessive neuronal 
firing. In addition, these cells are also capable of enhanced regulation at high K+ 0 
in the event that levels should exceed the normal physiological range. 
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Mechanistically, these results suggest that through an enhancement of glial 
regulatory processes, PHT may prevent the transition of interictal discharges to 
ictal episodes, an event that as suggested by Dichter et ale (1972) results from 
elevated K+ o. Furthermore, these results are consistent with the clinical ability 
of PHT to prevent the spread (ictal transition) from a seizure focus, but not the 
initiation process (interictal discharge). Because focal discharge is not prevented, 
it might be further reasoned that PHT is only able to enhance K+ 0 regulation in 
perifocal areas and not infiuence the regulatory ability of glial cells in the 
primary focus. 
Results of electrophysiological studies also support the hypothesis that PHT 
enhances regulation of K+ o. The data in Fig. 18 clearly demonstrate that for any 
given level of K+ 0' cells chronically exposed to PHT are likely to be less 
depolarized than controls. These data, therefore, fit with the expectation that 
protected tissues are less depolarized than susceptible ones for an equivalent 
concentration of K+ 0 (Somjen, 1975). During normal physiological activity, ECF 
K+ is maintained between 3 and 4 mM (see Prince et al., 1978); however, it can 
rise as high as 12 mM during seizures and has been observed to rise even higher 
(greater than 20 mM) during spreading depression (ViskocU et al., 1972; Futamachi 
et al., 1974; Somjen et al., 1976; Somjen, 1979). 
In light of evidence suggesting that increases in K+ 0 could affect neuronal 
firing, Pollen and Trachenberg in 1970 proposed that epilepsy could be the result of 
inadequate spatial buffering of K+ 0 by glial cells. Numerous studies have 
suggested that the subsequent removal of elevated K+ 0 is via an active 
accumulation into adjacent astrocytes. However, following the failure of several 
electrophysical studies to demonstrate any difference in baseline K+ 0 between 
normal and epileptogenic brains (Lux, 1974; Pedley et al., 1976) it was concluded 
that an impairment of glial buffering was an unlikely cause of paroxymal 
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depolarization shifts. However, as pointed out by Lewis et al., (1977), the highly 
localized and transient nature of relatively large K+ 0 electrodes could miss 
transient and localized increases in K+ 0 induced by bursts of high frequency firing 
associated with alumina gel foci (Lewis et al., 1977). These authors have also 
demonstrated, that within gliotic scars induced by local application of alumina 
gel, clearance of K+ 0 was slowed despite no observable difference in the base-line 
potassium level of epileptogenic and normal brain areas. The insensitivity of the 
K+ electrode in detecting fine kinetic characteristics of cation movement has 
been further discussed by Grisar et al., (1983). This recent report has examined in 
some detail the kinetic characteristics of Na+, K+-ATPase of synaptosomal and 
glial fractions isolated from normal and focal areas of epileptogenic brains. 
Results reported therein demonstrate that a significant defect in the ability of 
glial cells isolated from focal lesions to regulate elevated K+ 0 does exist. 
However, glial cells isolated from brain areas surrounding the lesion appeared to 
have an increased ability to regulate K+ 0 during periods of epileptiform 
\ 
discharges. The demonstration that exogenously administered compounds (i.e., 
PHT) are capable of enhancing the ability of the eNS to regulate K+ 0 (Figs. 14B 
and 18), through an interaction with glial cells, provides important insight into the 
etiology and the arrest of seizures. 
The average Em of undifferentiated control cells in the present study was 30 
to 60 mV less than that commonly reported for primary astroglial cultures 
(Kimelberg, et al., 1979; Bowman, et al., 1983; Walz and Hertz, 1983). Our 
methods for Em recording differ in several respects from those used in other 
investigations, and could contribute to the lower membrane potentials reported in 
this study. For example, our potentials were recorded from cells replated onto 
collagen-coated culture dishes at a K+ 0 of 5.4 mM. When confluent cultures are 
replated onto collagen-coated dishes, cells are removed from the forces of 
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contact inhibition, and begin to divide. That dividing cells have different 
electrophysiological properties is suggested by a previous observation illustrating 
the dependency of the Em on the age of the culture (data not shown). The Em of 
cells replated onto collagen has been observed to be significantly lower than "that 
measured from cells still attached to plastic culture dishes (C. Bowman-personal 
communication). One factor that contributes to the lower Em reported in this 
study is the higher K+ 0 (5.4 mM) of the HEPES buffer as compared to other 
studies (3.0 to 4.5 mM). Furthermore, since no deviation from a normal 
distribution could be demonstrated (Fig. 16), all stable membrane potentials were 
accepted regardless of potential. 
Acutely, concentrations of PHT greater than lO-5M (Figs. 14A and 17) 
appeared to decrease the efficiency of glial N a +, K+ -ATPase. One possible 
explanation for this apparent discrepancy is that PHT increases membrane 
perm eabili ty to N a + in glial cells. In so doing, N a + i increases and subsequently 
depolarizes the cell membrane. Previously, it has been demonstrated that PHT is 
capable of increasing the short-circuit current (SeC) across frog skin and toad 
bladder (Watson and Woodbury, 1972; Watson and Woodbury, 1973). In these 
models, the sec is a direct measure of active Na+ transport, and the increase in 
sec is the result of enhanced permeability of mucosal-side membrane to Na+ (for 
discussion see Woodbury et al., 1983). The link between glial cells, frog skin and 
toad bladder is that all 3 are epithelial cells and WOuld, therefore, be expected to 
respond to PHT in a similar manner. Thus, as the Na+i concentration increases 
with increasing PHT concentrations, the cell membrane is depolarized. Acutely, 
at concentrations greater than 1 x 10-5 .!Y!" Em progressively returned to control 
values (Fig. 17). This observation provides one explanation for the excitatory 
effects often observed clinically when plasma PHT concentrations become too 
high (Glaser, 1972; Lascelles et al., 1970; Levy, 1965; Patel de Crichton, 1968; 
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Roseman, 1961; Schriener, 1958; and Troupin and Ojemann, 1975). For example, in 
the presence of high therapeutic concentrations of PHT, glial cells may have a 
reduced ability to regulate K+ o. The resultant increase in K+ 0 concentrations 
leads to a nonspecific depolarization of surrounding neurons and a possible 
reduction in seizure control. However, PHT's excitatory effects could also be the 
result of its direct action to inhibit neuronal Na+, K+ -ATPase (For discussion, see 
preceeding report). 
That chronic PHT treatment of cultured glial cells did not affect the activity 
of HC03 --ATPase (Fig. 19) is of interest considering our previous observations in 
vivo (White et al., 1983; and preceeding paper-this issue). In these studies, a 
significant increase in cerebral cortex HC03 --ATPase activity was observed 
following chronic PHT treatment of adult rats (20 mg/kg, ip, bid for 7 days). 
Considering the postulated relationship between this enzyme and CO2-fixation 
reactions of the mitochondria (for discussion, see Woodbury, 1980), an increase in 
enzymic activity indirectly renects an increase in neuronal activity and thus CO2 
production. Our present results, therefore, do not necessarily constitute a 
conflict between in vivo and in vitro observations but instead suggest that the 
increased enzymic activity observed in vivo is indirectly related to PHT's direct 
stimulatory effect on neurons (White et al., 1983; and preceeding report, this 
issue), and dependent in part on the intimate relationship between neurons and glia 
found only in vivo. We are currently investigating the relationship between the 
activities of HC03 --ATPase and carbonic anhydrase and anion transport in 
primary glial cultures and their respective contribution to the maintenance of the 
Em· 
The increase in Ca++, Mg++-ATPase activity (Fig. 20) observed following 
chronic PHT-treatment of undifferentiated cells indirectly suggests that Ca++i 
concentrations are elevated. This conclusion is further supported by a previous 
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study wherein similar concentrations of PHT were observed to decrease Ca ++-
uptake into mitochondria, and hence increase Ca ++ i. A decrease in the Ca ++, 
Mg++-ATPase activity (Fig. 20) of DBcAMP-differentiated cells was seen 
following chronic treatment with PHT. This result suggest that the Ca ++ i 
concentration was decreased. Such an effect could be the indirect result of the 
decreased PNa/PK ratio (Fig. 20) also observed with chronic PHT-treatment of 
DBcAMP-differentiated cells. As the membrane permeability to sodium is 
decreased, less Na+ 0 leaks across the membrane. One means whereby the cell 
regulates N a + i is through a Ca ++ IN a + counter-transport process in which Ca ++ i is 
exchanged for Na+ 0 (Latzkovits and Fajszi, 1982). Thus in a compensatory 
attempt to regulate Na+i' the cell also decreases Ca++i. We are currently 
investigating why the response of the PNa/PK ratio and the Ca++, Mg++-ATPase 
enzyme to PHT is different in DBcAMP-differentiated cells as compared to 
undifferentiated fiat cells. 
The studies presented in this report provide important new biochemical and 
electrophysiological data demonstrating that both acute and chronic PHT 
treatment can have profound effects on isolated cultures of glial cells. Through 
an interaction with glial regulatory processes, PHT in therapeutic concentrations 
appears to provide the CNS with an enhanced ability to regulate K+ 0 homeostasis 
within the brain ECF thereby limiting the spread of seizure activity. 
Furthermore, it appears that its ability to interact with glial cells can contribute 
to the acute and chronic CNS toxicity associated with high doses of PHT. 
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